CISION PRNewswire

63144 posts
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — SiRNA technology offers distinct advantages over…
JETOUR T2 Debuts in the UAE, Featuring Advanced XWD Technology

JETOUR T2 Debuts in the UAE, Featuring Advanced XWD Technology

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ — On January 27th, 2024, JETOUR…
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

SHANGHAI and ROSELAND, N.J., Jan. 29, 2024 /PRNewswire/ — Oricell Therapeutics (Oricell),…
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — Peijia Medical Limited (Peijia, (9996.HK)),…
Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

CHARLOTTE, N.C., Jan. 29, 2024 /PRNewswire/ — Celgard, LLC (Celgard), a subsidiary…
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders

Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage pharmaceutical…
Dingdong Announces US.0 Million Share Repurchase Program

Dingdong Announces US$20.0 Million Share Repurchase Program

SHANGHAI, Jan. 29, 2024 /PRNewswire/ — Dingdong (Cayman) Limited ("Dingdong" or the…
Visionary Education Group Established a MOU with Algoma University

Visionary Education Group Established a MOU with Algoma University

TORONTO, Jan. 29, 2024 /PRNewswire/ — Visionary Education Technology Holdings Group Inc.…